Regulation

Liposomal Drug Delivery – Review
Public Policy Liposomal Drug Delivery – Review

Liposomal drug delivery systems stand at the forefront of innovative approaches in pharmaceutical technology, particularly in addressing challenging and rare diseases like biliary tract cancer (BTC). BTC, known for its aggressive progression and limited treatment efficacy, affects approximately

Are Non-Medical Educators Unfairly Treated in Medical Colleges?
Public Policy Are Non-Medical Educators Unfairly Treated in Medical Colleges?

In recent years, the landscape of medical education in India has become a battleground for educators from diverse academic backgrounds seeking equality in their professional rights and opportunities. As regulations evolve, non-medical faculty with MSc and PhD qualifications find themselves at the

How Can Predictive Maintenance Save Lives in Biopharma?
Technology How Can Predictive Maintenance Save Lives in Biopharma?

In this insightful discussion, we delve into the world of predictive maintenance with Faisal Zain, a healthcare expert specializing in medical technology. He brings a wealth of experience in manufacturing medical devices used for both diagnostics and treatment, driving innovation in the field. As

Telehealth Security Protocols – Review
Data and Information Telehealth Security Protocols – Review

The increasing use of digital health channels has made telehealth a staple in modern healthcare delivery. Yet, heightened scrutiny surrounds its security measures due to this surge in popularity. Statistically, in 2024, a staggering number of healthcare data breaches signaled the urgent need for

Proposed Medicaid Cuts Threaten Rural Healthcare Access
Public Policy Proposed Medicaid Cuts Threaten Rural Healthcare Access

The Trump administration's One Big Beautiful Bill Act has proposed significant Medicaid funding reductions, representing the largest in history and presenting alarming challenges for rural healthcare systems. With estimates suggesting that over 10 million Americans could lose coverage, the

Can Reyobiq Revolutionize Pediatric Brain Tumor Treatment?
Public Policy Can Reyobiq Revolutionize Pediatric Brain Tumor Treatment?

In a groundbreaking development for pediatric oncology, the U.S. Food and Drug Administration (FDA) has approved a clinical trial for Reyobiq (Rhenium Re186 Obisbemeda), a promising radiation therapy aimed at treating aggressive brain tumors in children. This trial has generated significant

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later